3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
US-2020002298-A1 · Jan 2, 2020 · US
This page is not indexed by search engines while we improve data quality.
Davis Heather patents
Davis Heather is listed as an inventor on 24 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Davis Heather |
| Total patents | 24 |
| First publication | Apr 16, 2015 |
| Latest publication | Jan 2, 2020 |
Notable patents
Publications ranked by popularity score, then publication date.
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
US-10464910-B2 · Nov 5, 2019 · US
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
US-10464909-B2 · Nov 5, 2019 · US
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
US-10457652-B2 · Oct 29, 2019 · US
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
US-10442776-B2 · Oct 15, 2019 · US
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
US-10421732-B2 · Sep 24, 2019 · US
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
US-2019127339-A1 · May 2, 2019 · US
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
US-2019119227-A1 · Apr 25, 2019 · US
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
US-2019119230-A1 · Apr 25, 2019 · US
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
US-2019119229-A1 · Apr 25, 2019 · US
Recent patents
Latest publications not already listed above.
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
US-2019119228-A1 · Apr 25, 2019 · US
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
US-10214500-B2 · Feb 26, 2019 · US
Selectively substituted quinoline compounds
US-RE47193-E · Jan 8, 2019 · US
Selectively substituted quinoline compounds
US-2018354939-A1 · Dec 13, 2018 · US
Selectively substituted quinoline compounds
US-2018030045-A1 · Feb 1, 2018 · US
3-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitors
US-9637453-B2 · May 2, 2017 · US
3-spiro-7-hydroxamic acid tetralins as HDAC inhibitors
US-9630922-B2 · Apr 25, 2017 · US
Selectively substituted quinoline compounds
US-2016326161-A1 · Nov 10, 2016 · US
3-spirocyclic-6-hydroxamic acid tetralins as hdac inhibitors
US-2016304456-A1 · Oct 20, 2016 · US
3-spiro-7-hydroxamic acid tetralins as hdac inhibitors
US-2016304462-A1 · Oct 20, 2016 · US
Selectively substituted quinoline compounds
US-9428495-B2 · Aug 30, 2016 · US
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
US-2016222028-A1 · Aug 4, 2016 · US
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
US-2016222022-A1 · Aug 4, 2016 · US
Selectively substituted quinoline compounds
US-2015105370-A1 · Apr 16, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Forma Therapeutics Inc | 18 |
| Eisai R&D Man Co Ltd | 6 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D471/04 | 24 |
| C07D413/14 | 20 |
| C07D401/10 | 20 |
| A61K31/553 | 20 |
| C07D413/04 | 20 |